Does adding myofascial release (a type of soft tissue manipulation) to silicone patches improve Caesarean scar healing more than using silicone patches alone?

The effect of selected therapeutic (myofascial relaxation techniques and silicone patches) interventions on the biomechanical properties of scar tissue after Caesarean section

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10914133

Enrollment

Registered

2019-12-20

Start date

2020-01-15

Completion date

Unknown

Last updated

2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scarring after Caesarean section Skin and Connective Tissue Diseases

Interventions

Participants will be randomly assigned to one of two comparison groups. Randomization using a 1:1 randomization scheme will be carried out using computer-generated random numbers (simple randomization

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women after Caesarean section within 6 weeks of surgery (transverse cut using the Pfannenstiel method) 2. Full healing of the wound after the scab falls off 3. Healthy on the day of the test 4. End of the puerperium period 5. Aged 18-45 years

Exclusion criteria

Exclusion criteria: 1. Caesarean section was less than 6 weeks or more than 12 weeks previously 2. Incomplete wound healing (exudate, local inflammation) 3. Malaise on the day of the test 4. Caesarean section in multiple pregnancies 5. Lack of consent of the examined person

Design outcomes

Primary

Measure	Time frame
1. Scar tissue tone assessed using the MyotonPRO digital palpation device before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention 2. Scar tissue stiffness assessed using the MyotonPRO digital palpation device before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention 3. Scar tissue elasticity assessed using the MyotonPRO digital palpation device before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention	—

Measure

Time frame

1. Scar tissue tone assessed using the MyotonPRO digital palpation device before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention 2. Scar tissue stiffness assessed using the MyotonPRO digital palpation device before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention 3. Scar tissue elasticity assessed using the MyotonPRO digital palpation device before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention

—

Secondary

Measure	Time frame
1. Scar severity (comprising vascularity, height/thickness, pliability, and pigmentation) assessed using the Vancouver Scar Scale before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention 2. Scar pain assessed using a visual analogue scale (VAS) before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention	—

Measure

Time frame

1. Scar severity (comprising vascularity, height/thickness, pliability, and pigmentation) assessed using the Vancouver Scar Scale before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention 2. Scar pain assessed using a visual analogue scale (VAS) before the start of the intervention, immediate after the end of the intervention and 1 month and 6 months after the end of the intervention

—

Countries

Poland

Contacts

Public ContactMalgorzata Pasternok

pasmal@wp.pl+48 506174008

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026